Skip to main content

Table 1 Recommended ASCVD risk enhancing factors for individuals with borderline and intermediate-risk

From: The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study

Family history of premature CVD

Persistently elevated LDL-C ≥ 160 mg/dl

Chronic kidney disease

Metabolic syndrome

Condition-specific to women (e.g. HDP, premature menopause, GDM/macrosomia)

Inflammatory disease (especially rheumatoid arthritis, psoriasis, HIV)

Ethnicity (e.g. south Asian ancestry)

Lipid biomarkers

 Persistently elevated triglycerides ≥ 175 mg/dl

In selected individuals, if measured

 hs-CRP ≥ 2 mg/dl

 LP (a) levels ≥ 50 mg/dl

 apoB ≥ 130 mg/dl

 Ankle-brachial index (ABI) < 0.9

  1. CVD cardiovascular disease, LDL-C low-density lipoprotein cholesterol, hs-CRP highly sensitive C-reactive protein; LP (a) lipoprotein (a), GDM gestational diabetes, HDP hypertensive disorders pregnancy
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us